-+ 0.00%
-+ 0.00%
-+ 0.00%

Filana Therapeutics director Michael O'Donnell to resign after annual meeting

PUBT·04/28/2026 20:07:50
Listen to the news
Filana Therapeutics director Michael O'Donnell to resign after annual meeting
  • Filana Therapeutics director Michael O'Donnell plans to resign from board at conclusion of 2026 annual meeting of stockholders.
  • O'Donnell will remain on board until resignation takes effect.
  • Departure was not tied to any disagreement with Filana, management, or board over operations, policies, or practices.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Filana Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-013638), on April 28, 2026, and is solely responsible for the information contained therein.